Formulations

Kase Farma Engineers formulate product with outdoor grown, superior genetic hemp, sourced from IPElite™ and IPGrowers™ in California and Saskatchewan. Kase Farma prides itself in providing customers with full transparency as to the IP plant origin of their products and the integrity and, science utilized in the extraction and formulation of Kase One – “One Plant; One Life”, bringing accountability and verified quality to the cannabinoid industry.

Kase One provides a premium health and wellness product to assist in maintaining an overall balance in body and mind.

Kase is an industry leader driven by quality, integrity and innovation, managed by a world-class team of experts with more than 50 years of combined expertise. We are one of the first volatile and non-volatile hemp extraction manufacturing labs approved for operations in the State of California.

Our 22,000 sq. ft. facility (which is currently implementing a scaled-up extraction strategy for a high through put IPGrowTM hemp-based cannabinoid plant within the existing facility), provides full research and production equipment that ensures ongoing quality control and purity of product.

Our pedigree is founded on a history of Full Spectrum innovative formulation and proven products that we have developed in our laboratories and formulation plants.

Current Products:

  • Tinctures: commonly used to improve immune, neurological, muscular and mental health
  • Full spectrum oil blends: commonly used to improve immune, neurological, muscular and musculoskeletal health
  • Wholesale crude: Full Spectrum bulk product
  • Wholesale distillate: low to high potency, pure and solvent free ready to be used for various consumption methods
  • White label topicals: various topicals available for rebranding
  • Co-manufacturing agreements for tinctures and vapes: working with various company’s to create specific manufactured products

Kase Farma is innovating, formulating and improving our products. Some of the new processes and product offers we are working on include:

  • CBN conversions utilizing a Kase proprietary process
  • CBG formulations and products
  • CBD topicals that will launch in the US, Canada and the UK in early 2020
  • Adaptive water solubility capability

At Kase Farma, the thought process has always centered around forward thinking. In cannabis, the industry has been focused on THC and CBD, as they are the most prevalent compounds in cannabis and hemp plants. The question that begs to be asked; are these two compounds, 2 of 113 cannabinoids, truly the most desirable from a wellness and medical value approach? As we learn more about the other 111 cannabinoids, there has been a lot of focus on the CBG and CBN compounds.

The CBG cannabinoid is the precursor to all other cannabinoids and it is believed to have a significant impact directly on the endocannabinoid system, unlike CBD, which acts more as a guide for other compounds to bind to the body’s CB receptors. Kase Farma's approach to CBG revolves around first identifying high-CBG genetics in order to have access to larger volumes of identity preserved biomass through our IPGrow™ partners. At Kase Farma we believe that the highest degree of benefit comes from utilizing the Full Spectrum of the hemp plant, and our focus in terms of CBG, will follow this train of thought as we implement this CBG wellness strategy. Along with Full Spectrum CBG extraction we are also working on isolation of the CBG compound through crystallization techniques that will allow Kase Farma to produce the highest quality and purity CBG products available, whether they be packaged consumer goods or bulk ingredients.

CBN has long been a concern of cultivators and extractors because the presence of CBN usually means that some of the THC or CBD has degraded and lost value. As more and more research is underway, we are seeing that CBN may actually be more beneficial than the two precursors mentioned. Just like CBG, CBN fits directly into the CB receptors in the body’s endocannabinoid system. Preliminary data shows this molecule to be an effective sedative without any psycho activity. Looking forward, we believe there to be significant medical value to this material and our Kase proprietary processes will convert cannabinoids into high CBN oil ready for isolation and purification. Our proprietary process through a longer time cycle does not utilize any other additives or catalysts that might leave a nasty residue and require clean up processing. Our belief is that the Full Spectrum of the hemp plant would be the most beneficial, and we continue to work to analyze and reconstitute what the remaining spectrum might include along with the CBN we are able to produce.

 

Image
Image
Image

Kase Farma, An Industry Leader

Kase Farma is an industry leader driven by quality, integrity and innovation, managed by a world-class team of experts. Kase Farma currently operates out of a 22,000 sq. ft. manufacturing facility and is currently implementing a scaled-up, high through put extraction strategy utilizing IPGrow hemp-based cannabinoid plant within the existing facility. Kase Farma is licensed to operate in the areas of cultivation, extraction and distribution in the State of California, and is world renowned for its products that have been shown to assist with the reduction of certain medical conditions.

Learn More
 

Contact Us
4111 Brew Master Dr 
Ceres, CA
95307, USA

Phone: 209-622-4580 
Email: mike@starlingbrands.com